Apellis Pharmaceuticals (APLS) stock falls as Goldman Sachs downgrades the company, citing competitive risks and a gloomier sales outlook. Read more here.
Apellis stock cut to sell at Goldman Sachs (APLS:NASDAQ)
Apellis Pharmaceuticals (APLS) stock falls as Goldman Sachs downgrades the company, citing competitive risks and a gloomier sales outlook. Read more here.